Optimization of conditions for secretion of dengue virus type 2 envelope domain III using Pichia pastoris

被引:27
|
作者
Batra, Gaurav [1 ]
Gurramkonda, Chandrasekhar [1 ]
Nemani, Satish Kumar [1 ]
Jain, Swatantra Kumar [2 ]
Swaminathan, Sathyamangalam [1 ]
Khanna, Navin [1 ]
机构
[1] Int Ctr Genet Engn & Biotechnol, RGP Grp, New Delhi 110067, India
[2] Jamia Hamdard, Dept Biotechnol, New Delhi 110062, India
关键词
Dengue; Flavivirus; Envelope domain III; Pichia pastoris; Fed-batch cultivation; Vaccine; NEUTRALIZING ANTIBODIES; ESCHERICHIA-COLI; PROTEIN; EXPRESSION; GLYCOPROTEIN; INDUCTION; EPITOPES; ANTIGEN; VACCINE; BINDING;
D O I
10.1016/j.jbiosc.2010.05.001
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
We have developed a recombinant clone of the methylotrophic yeast Pichia pastoris capable of secreting dengue virus type 2 envelope domain III (sEDIII-2). We explored various induction parameters including media composition, temperature, pH, and methanol concentration, to optimize conditions for sEDIII-2 expression in shake flask culture. Induction at 20 degrees C in the presence of 2% (v/v) methanol in a medium buffered to pH 5.8 resulted in highest secretion of 5EDIII-2. This yield could be further enhanced up to 70% by repeated induction of the same initial biomass. Using a fed-batch cultivation strategy, we observed that shake-flask yields can be scaled up similar to 8-fold in a bioreactor. We obtained similar to 94% purity with >70% recovery after purification. This study, which demonstrates for the first time the feasibility of secreting envelope domain III using the P. pastoris host, will be relevant to sub-unit approaches to dengue vaccine development. (C) 2010, The Society for Biotechnology, Japan. All rights reserved.
引用
收藏
页码:408 / 414
页数:7
相关论文
共 50 条
  • [41] Recombinant dengue virus type 2 envelope/hepatitis B surface antigen hybrid protein expressed in Pichia pastoris can function as a bivalent immunogen
    Bisht, H
    Chugh, DA
    Raje, M
    Swaminathan, S
    Khanna, N
    JOURNAL OF BIOTECHNOLOGY, 2002, 99 (02) : 97 - 110
  • [42] A synthetic peptide derived from domain III envelope glycoprotein of Dengue virus induces neutralizing antibody
    Mary, J. Asnet
    Jittmittraphap, Akanitt
    Chattanadee, Siriporn
    Leaungwutiwong, Pornsawan
    Shenbagarathai, R.
    VIRUS GENES, 2018, 54 (01) : 25 - 32
  • [43] Novel interactions of domain III from the envelope glycoprotein of dengue 2 virus with human plasma proteins
    Huerta, Vivian
    Ramos, Yassel
    Yero, Alexis
    Pupo, Dianne
    Martin, Dayron
    Toledo, Patricia
    Fleitas, Noralvis
    Gallien, Sebastien
    Martin, Alejandro M.
    Marquez, Gabriel J.
    Perez-Riverol, Yasset
    Sarria, Monica
    Guirola, Osmany
    Gonzalez, Luis J.
    Domon, Bruno
    Chinea, Glay
    JOURNAL OF PROTEOMICS, 2016, 131 : 205 - 213
  • [44] Antibodies Induced by Dengue Virus Type 1 and 2 Envelope Domain III Recombinant Proteins in Monkeys Neutralize Strains with Different Genotypes
    Bernardo, Lidice
    Fleitas, Osmel
    Pavon, Alequis
    Hermida, Lisset
    Guillen, Gerardo
    Guzman, Maria G.
    CLINICAL AND VACCINE IMMUNOLOGY, 2009, 16 (12) : 1829 - 1831
  • [45] Pichia pastoris-Expressed Dengue 2 Envelope Forms Virus-Like Particles without Pre-Membrane Protein and Induces High Titer Neutralizing Antibodies
    Mani, Shailendra
    Tripathi, Lav
    Raut, Rajendra
    Tyagi, Poornima
    Arora, Upasana
    Barman, Tarani
    Sood, Ruchi
    Galav, Alka
    Wahala, Wahala
    de Silva, Aravinda
    Swaminathan, Sathyamangalam
    Khanna, Navin
    PLOS ONE, 2013, 8 (05):
  • [46] Optimization of codon usage of the envelope protein E2 gene from various genotypes of hepatitis C virus to predict the expression level in Pichia pastoris
    Perumal, Ponniah Saravana
    Wilson, Stevin
    Santhiagu, Arockiasamy
    GENES & GENOMICS, 2016, 38 (10) : 977 - 984
  • [47] High expression of consensus dengue virus envelope glycoprotein domain III using a viral expression system in tobacco
    Kim, Mi-Young
    Jang, Yong-Suk
    Yang, Moon-Sik
    Kim, Tae-Geum
    PLANT CELL TISSUE AND ORGAN CULTURE, 2015, 122 (02) : 445 - 451
  • [48] Dengue virus envelope domain III immunization elicits predominantly cross-reactive, poorly neutralizing antibodies localized to the AB loop: implications for dengue vaccine design
    Li, Xiao-Quan
    Qiu, Li-Wen
    Chen, Yue
    Wen, Kun
    Cai, Jian-Piao
    Chen, Jing
    Pan, Yu-Xian
    Li, Jie
    Hu, Dong-Mei
    Huang, Yan-Fen
    Liu, Li-Dong
    Ding, Xi-Xia
    Guo, Yong-hui
    Che, Xiao-Yan
    JOURNAL OF GENERAL VIROLOGY, 2013, 94 : 2191 - 2201
  • [49] Phage Display Approaches for the Isolation of Monoclonal Antibodies Against Dengue Virus Envelope Domain III from Human and Mouse Derived Libraries
    Moreland, Nicole J.
    Susanto, Patricia
    Lim, Elfin
    Tay, Moon Y. F.
    Rajamanonmani, Ravikumar
    Hanson, Brendon J.
    Vasudevan, Subhash G.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (03) : 2618 - 2635
  • [50] Domain-III FG loop of the dengue virus type 2 envelope protein is important for infection of mammalian cells and Aedes aegypti mosquitoes
    Erb, Steven M.
    Butrapet, Siritorn
    Moss, Kelley J.
    Luy, Betty E.
    Childers, Thomas
    Calvert, Amanda E.
    Silengo, Shawn J.
    Roehrig, John T.
    Huang, Claire Y. -H.
    Blair, Carol D.
    VIROLOGY, 2010, 406 (02) : 328 - 335